Group


38 results

Financial information

Ipsen announces 3.1% Group Sales Growth, reinstates 2020 gui...

We are pleased to announce that our Business Development team will be led by Philippe…

Group

David Loew joins Ipsen as CEO

We are pleased to announce that our Business Development team will be led by Philippe…

Group

Fulfilling our commitment to employees and mission to patien...

We are pleased to announce that our Business Development team will be led by Philippe…

Financial information

FY2019 and beyond: paving the way for our next phase of grow...

We are pleased to announce that our Business Development team will be led by Philippe…

Group

2020 priorities: our path forward is clear

We are pleased to announce that our Business Development team will be led by Philippe…

Group

Demerger of Mayroy SA and Internal reclassification of Ipsen...

We are pleased to announce that our Business Development team will be led by Philippe…

Group

Ipsen completes acquisition of Clementia Pharmaceuticals

We are pleased to announce that our Business Development team will be led by Philippe…

Group

Building the market access ecosystem

We are pleased to announce that our Business Development team will be led by Philippe…

Group

Ipsen acquisition of Clementia Pharmaceuticals – Confe...

We are pleased to announce that our Business Development team will be led by Philippe…

Group

Ipsen commits to making all its published scientific researc...

We are pleased to announce that our Business Development team will be led by Philippe…

Group

Ipsen: a story of transformation and growth

We are pleased to announce that our Business Development team will be led by Philippe…

Group

Ipsen Seasons greetings

We are pleased to announce that our Business Development team will be led by Philippe…

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2022